Home

#236 ‒ Neurodegenerative disease: pathology, screening, and prevention | Kellyann Niotis, M.D.

2023/1/2

The Peter Attia Drive

Frequently requested episodes will be transcribed first

Chapters

Shownotes Transcript

No transcript made for this episode yet, you may request it for free.

#236 ‒ Neurodegenerative disease: pathology, screening, and prevention | Kellyann Niotis, M.D.

The Peter Attia Drive

Chapters

Who is Kellyann Niotis and what sparked her interest in neurodegeneration?

What are the different types of neurodegenerative diseases and how prevalent are they?

Overview of Parkinson’s disease and neuromuscular disorders including ALS

What are the early signs and genetic factors of Parkinson’s disease?

How can sleep and anxiety affect the onset of Parkinson’s disease?

What challenges exist in standardizing early interventions for Parkinson’s disease?

Understanding the pathophysiology of Alzheimer’s disease and the role of amyloid and tau proteins

Can PET scans accurately diagnose Alzheimer’s disease?

How can tau accumulation and serum biomarkers help in early detection of Alzheimer’s disease?

What is involved in cognitive testing for neurodegenerative diseases?

Why have drugs failed to show efficacy in treating Alzheimer’s disease?

Is there a link between hearing loss and dementia?

How does oral health relate to neurodegenerative diseases?

What genetic risks are associated with Alzheimer’s disease?

What can mitochondrial haplotypes reveal about neurodegenerative disease risk?

What role does exercise play in maintaining brain health?

Is high blood pressure a risk factor for neurodegenerative diseases?

Why are women more affected by Alzheimer’s disease?

What are the future prospects for understanding and preventing neurodegenerative diseases?

Shownotes Transcript

#236 ‒ Neurodegenerative disease: pathology, screening, and prevention | Kellyann Niotis, M.D. 01:56:43 Share

The Peter Attia Drive

Chapters

Who is Kellyann Niotis and what sparked her interest in neurodegeneration?

What are the different types of neurodegenerative diseases and how prevalent are they?

Overview of Parkinson’s disease and neuromuscular disorders including ALS

What are the early signs and genetic factors of Parkinson’s disease?

How can sleep and anxiety affect the onset of Parkinson’s disease?

What challenges exist in standardizing early interventions for Parkinson’s disease?

Understanding the pathophysiology of Alzheimer’s disease and the role of amyloid and tau proteins

Can PET scans accurately diagnose Alzheimer’s disease?

How can tau accumulation and serum biomarkers help in early detection of Alzheimer’s disease?

What is involved in cognitive testing for neurodegenerative diseases?

Why have drugs failed to show efficacy in treating Alzheimer’s disease?

Is there a link between hearing loss and dementia?

How does oral health relate to neurodegenerative diseases?

What genetic risks are associated with Alzheimer’s disease?

What can mitochondrial haplotypes reveal about neurodegenerative disease risk?

What role does exercise play in maintaining brain health?

Is high blood pressure a risk factor for neurodegenerative diseases?

Why are women more affected by Alzheimer’s disease?

What are the future prospects for understanding and preventing neurodegenerative diseases?

Shownotes Transcript

#236 ‒ Neurodegenerative disease: pathology, screening, and prevention | Kellyann Niotis, M.D.